Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer

NCT02974933 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Nonsmall Cell Lung Cancer

Interventions

DRUG: Apatinib combined with pemetrexed

Sponsor

Wuling Ou

Collaborators

[object Object]
[object Object]